Quantitative in vivo and in vitro sex differences in artemisinin metabolism in rat

Xenobiotica

Volumn 29, Issue 2, 1999, Pages 195-204

  Ashton, M ^a   Johansson, L ^a   Thornqvist, A S ^a   Svensson, U S H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ARTEMISININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; EMULSION; ERYTHROCYTE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; NONHUMAN; PLASMA CLEARANCE; RAT; SEX DIFFERENCE;

ANIMALIA; CAPRA HIRCUS; ORYCTOLAGUS CUNICULUS;

EID: 0032910248     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238740     Document Type: Article

References (30)

1. ASHTON, M., SY, N. D., GORDI, T., HAI, T. N., THACH, D. C., HUONG, N. V., NIEU, N. T., FARAH, M. H., JOHANSSON, M. and CÔNG, L. D., 1996, Evidence for time-dependent artemisinin kinetics in patients with uncomplicated malaria. Pharmaceutical and Pharmacological Letters, 6, 127-130.
2. ASHTON, M., SY, N. D., HUONG, N. V., GORDI, T., HAI, T. N., HUONG, D. X., NIEU, N. T. and CÔNG, L. D., 1998a, Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria. Clinical Pharmacology and Therapeutics, 63, 482-492.
3. ASHTON, M., HAI, T. N., SY, N. D., HUONG, D. X., HUONG, N. V., NIĒU, N. T. and CÔNG, L. D., 1998b, Artemisinin pharmacokinetics is time-dependent in healthy subjects. Drug Metabolism and Disposition, 26, 25-27.
4. BAKHSHI, H., GORDI, T. and ASHTON, M., 1997, In-vitro interaction between artemisinin and intact erythrocytes, erythrocyte ghosts, haemoglobin and carbonic anhydrase, Journal of Pharmacy and Pharmacology, 49, 223-226.
5. BREWER, T. O., GRATE, S. J., PEGGINS, J. O., WEINA, P. J., PETRAS, J. M., LEVINE, B. S., HEIFFER, M. H. and SCHUSTER, B. G., 1994, Fatal neurotoxicity of arteether and artemether. American Journal of Tropical Medicine and Hygiene., 51, 251-59.
6. DIEN, T. K., DE VRIES, P. J., KHANH, N. X., KOOPMANS, R., BINH, L. N., DUC, D. D., KAGER, P. A. and VAN BOXTEL, C. J., 1997, Effect of food intake on pharmacokinetics of oral artemisinin in healthy Vietnamese subjects. Antimicrobial Agents and Chemotherapy, 41, 1069-1072.
7. EDLUND, P. O., WESTERLUND, D, CARLQVIST, J, BO-LIANG, W. and YUNHUA, J., 1994, Determination of artesunate and dihydroartemisinine in plasma by liquid chromatography with post-column derivatization and UV-detection. Acta Pharmaceutica Suecica, 21, 223-234.
8. HIEN, T. T. and WHITE, N. J., 1993, Qinghaosu. Lancet, 341, 603-608.
9. KAICUN, Z. and ZHENYU, S., 1989, Distribution and excretion of artesunate in rats. Proceedings of the Chinese Academy of Medical Sciences and the Peking Union Medical College, 4, 186-188.
10. KLAYMAN, D. L., 1985, Qinghaosu (artemisinin): an antimalarial drug from China. Science, 228, 1049-1055.
11. HUFFORD, C.-D., LEE, E. E. I.-S., ELSOHLY, H. N., CHI, H. T. and BAKER, J. K., 1990, Structure elucidation and thermospray high-performance liquid chromatography/mass spectroscopy (HPLC/MS) of the microbial and mammalian metabolites of the antimalarial arteether. Pharmaceutical Research, 7, 923-927.
12. LESKOVAC, V. and THEOHARIDES, A. D., 1991, Hepatic metabolism of artemisinin drugs - I. Drug metabolism in rat liver microsomes. Comparative Biochemistry and Physiology, 99C, 383-390.
13. LI, Q.-G., PEGGINS, J. O., FLECKENSTEIN, L. L., MASONIC, K., HEIFFER, M. H. and BREWER, T. G., 1998, The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. Journal of Pharmacy and Pharmacology, 50, 173-182.
14. LIN J. H., CHIBA M., CHEN I. W., NISHIME J. A. and VASTAG, K. J., 1996, Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence. Drug Metabolism and Disposition, 24, 1298-1306.
15. LIDDLE, C., MODE, A., LEGRAVEREND, C. and GUSTAVSSON, J. A., 1992, Constitutive expression and hormonal regulation of male sexually differentiated cytochrome P450 in primary cultured rat hepatocytes. Archives in Biochemistry and Biophysics, 298, 159-166.
16. LOWRY, O. H., ROSEBROUGH, N. J. and RANDALL, R. J., 1951, Colorimetric determinations of proteins. Journal of Biological Chemistry, 193, 265-275.
17. MAURIZIS, J. C., MADELMONT, J. C., RAPP, M., MARIJNEN, C., CERF, M. C., GILLARDIN, J. M., LEPAGE, F. and VEYRE, A., 1997, Disposition and metabolism of 2,6-dimethylbenzamide N-(5-methyl-3-isoxazolyl) (D2916) in male and female rats. Drug Metabolism and Disposition, 25, 33-39.
18. MESHNICK, S. R., TAYLOR, T. E. and KAMCHONWONGPAISAN, S., 1996, Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiological Reviews, 60, 301-315.
19. NIU, X. Y., HO, L. Y., REN, Z. H. and SONG, Z. Y., 1985, Metabolic fate of qinghaosu in rats; a new TLC densiometric method for its determination in biological material. European Journal of Drug Metabolism and Pharmacokinetics, 10, 55-59.
20. ROWLAND, M. and TOZER, T. N., 1995, Clinical Pharmacokinetics: Concepts and Applications, 3rd edn (Baltimore: Williams & Wilkins), pp. 137-155.
21. SHAH, V. P., MIDHA, K. K., DIGHE, S., MCGILVERAY, I. J., SKELLY, J. P., YACOBI, A., LAYLOFF, T., VISWANATHAN, C. T., COOK, C. E., MCDOWALL., R. D., PITTMAN, K. A. and SPECTOR, S., 1992, Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharmaceutical Research, 9, 588-592.
22. SHIMADA, M., MURAYAMA, N., NAGATA, K., HASHIMOTO, H., ISHIKAWA, H. and YAMAZOE, Y., 1997, A specific loss of growth hormone abolished sex-dependent expression of hepatic cytochrome P450 in dwarf rats: reversal of the profiles by growth hormone-treatment. Archives of Biochemistry and Biophysics, 337, 34-42.
23. SIDHU, J. S. and ASHTON, M., 1997, Single-dose comparative study of venous, capillary and salivary artemisinin concentrations in healthy male, adults. American Journal of Tropical Medicine and Hygiene, 56, 13-16.
24. SIDHU, J. S., ASHTON, M., HUONG, N. V., HAI, T. N., KARLSSON, M. O., SY, N. D., JONSSON, E. N. and CONG, L. D., 1998, Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria. British Journal of Clinical Pharmacology, 45, 347-354.
25. THOMPSON, K. L., VINCENT, S. H., MILLER, R. R., COLLETTI, A. E., ALVARO, R. F., WALLACE, M. A., FEENEY, W. P. and LEE CHIU, S.-H., 1997, Pharmacokinetics and disposition of the oxytocin receptor antagonist L-3868,899 in rats and dogs. Drug Metabolism and Disposition, 25, 1113-1118.
26. TITULAER, H. A. C., ELING, W. M. C. and ZUIDEMA, J., 1993, Pharmacokinetic and pharmacodynamic aspects of artelinic acid in rodents. Journal of Pharmacy and Pharmacology, 45, 830-835.
27. UNDP/WORLD BANK/WHO SPECIAL PROGRAMME FOR RESEARCH AND TRAINING IN TROPICAL DISEASES, 1981, The Development of Qinghaosu and its Derivatives as an Antimalarial Drug. IV. Meeting of the Scientific Working Group on the Chemotherapy of Malaria, China, 6 10 October 1981 (Meeting report). [Addendum: YANG, L.-X., Studies on the toxicity of qinghaosu and its derivatives (China Cooperative Research Group on Qinghaosu and its Derivatives as Anti-malarials).]
28. DE VRIES, P. J. and DIEN, T. K., 1996, Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs, 52, 818-836.
29. WAXMAN, D. J. and CHANG, T. K. H., 1995, Hormonal regulation of liver cytochrome P450 enzymes. In P. R. Ortiz de Montellano (ed.), Cytochrome P450, Structure, Mechanism and Biochemistry (New York: Plenum), pp. 391-418.
30. WAXMAN, D. J., RAM, P. A., PAMPORI, N. A. and SHAPIRO, B. H., 1995, Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered hormone deficient by neonatal monosodium glutamate. Molecular Pharmacology, 48, 790-797.